Inhibition of lysophosphatidic acid increase by prestorage whole blood leukoreduction in autologous CPDA-1 whole blood

Transfusion

Volumn 53, Issue 12, 2013, Pages 3139-3148

  Nagura, Yutaka ^b   Tsuno, Nelson H ^a   Ohkawa, Ryunosuke ^b   Nojiri, Takahiro ^b   Tokuhara, Yasunori ^b   Matsuhashi, Mika ^b   Yatomi, Yutaka ^b   Takahashi, Koki ^b  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE CITRATE PHOSPHATE GLUCOSE; AUTOTAXIN; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE; PRESERVATIVE; SPHINGOMYELIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIOACCUMULATION; BLOOD; BLOOD AUTOTRANSFUSION; BLOOD FILTER; BLOOD FILTRATION; BLOOD SAMPLING; BLOOD STORAGE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; LEUKAPHERESIS; LEUKOCYTE COUNT; LIPID STORAGE; PHOSPHOLIPID BLOOD LEVEL; PROTEIN BLOOD LEVEL;

ACUTE LUNG INJURY; BLOOD PRESERVATION; BLOOD TRANSFUSION; HUMANS; LYSOPHOSPHATIDYLCHOLINES; LYSOPHOSPHOLIPIDS;

EID: 84890442459     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12152     Document Type: Article

References (59)

1. Bux J,. Transfusion-related acute lung injury (TRALI): a serious adverse event of blood transfusion. Vox Sang 2005; 89: 1-10.
2. Silliman CC, Fung YL, Ball JB, Khan SY,. Transfusion-related acute lung injury (TRALI): current concepts and misconceptions. Blood Rev 2009; 23: 245-255.
3. Silliman CC, McLaughlin NJ,. Transfusion-related acute lung injury. Blood Rev 2006; 20: 139-159.
4. Vlaar AP, Hofstra JJ, Kulik W, van, Lenthe H, Nieuwland R, Schultz MJ, Levi MM, Roelofs JJ, Tool AT, de, Korte D, Juffermans NP,. Supernatant of stored platelets causes lung inflammation and coagulopathy in a novel in vivo transfusion model. Blood 2010; 116: 1360-1368.
5. Vlaar AP, Hofstra JJ, Levi M, Kulik W, Nieuwland R, Tool AT, Schultz MJ, de, Korte D, Juffermans NP,. Supernatant of aged erythrocytes causes lung inflammation and coagulopathy in a "two-hit" in vivo syngeneic transfusion model. Anesthesiology 2010; 113: 92-103.
6. Silliman CC, Paterson AJ, Dickey WO, Stroneck DF, Popovsky MA, Caldwell SA, Ambruso DR,. The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study. Transfusion 1997; 37: 719-726.
7. Vlaar AP, Hofstra JJ, Determann RM, Veelo DP, Paulus F, Kulik W, Korevaar J, de, Mol BA, Koopman MM, Porcelijn L, Binnekade JM, Vroom MB, Schultz MJ, Juffermans NP,. The incidence, risk factors, and outcome of transfusion-related acute lung injury in a cohort of cardiac surgery patients: a prospective nested case-control study. Blood 2011; 117: 4218-4225.
8. Toy P, Gajic O, Bacchetti P, Looney MR, Gropper MA, Hubmayr R, Lowell CA, Norris PJ, Murphy EL, Weiskopf RB, Wilson G, Koenigsberg M, Lee D, Schuller R, Wu P, Grimes B, Gandhi MJ, Winters JL, Mair D, Hirschler N, Sanchez Rosen R, Matthay MA,; TRALI Study Group. Transfusion-related acute lung injury: incidence and risk factors. Blood 2012; 119: 1757-1767.
9. Vlaar AP, Cornet AD, Hofstra JJ, Porcelijn L, Beishuizen A, Kulik W, Vroom MB, Schultz MJ, Groeneveld AB, Juffermans NP,. The effect of blood transfusion on pulmonary permeability in cardiac surgery patients: a prospective multicenter cohort study. Transfusion 2012; 52: 82-90.
10. Silliman CC, Bjornsen AJ, Wyman TH, Kelher M, Allard J, Bieber S, Voelkel NF,. Plasma and lipids from stored platelets cause acute lung injury in an animal model. Transfusion 2003; 43: 633-640.
11. Silliman CC, Voelkel NF, Allard JD, Elzi DJ, Tuder RM, Johnson JL, Ambruso DR,. Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J Clin Invest 1998; 101: 1458-1467.
12. Silliman CC, Boshkov LK, Mehdizadehkashi Z, Elzi DJ, Dickey WO, Podlosky L, Clarke G, Ambruso DR,. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood 2003; 101: 454-462.
13. Silliman CC, Clay KL, Thurman GW, Johnson CA, Ambruso DR,. Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase. J Lab Clin Med 1994; 124: 684-694.
14. Silliman CC, Elzi DJ, Ambruso DR, Musters RJ, Hamiel C, Harbeck RJ, Paterson AJ, Bjornsen AJ, Wyman TH, Kelher M, England KM, McLaughlin- Malaxecheberria N, Barnett CC, Aiboshi J, Bannerjee A,. Lysophosphatidylcholines prime the NADPH oxidase and stimulate multiple neutrophil functions through changes in cytosolic calcium. J Leukoc Biol 2003; 73: 511-524.
15. Silliman CC, Dickey WO, Paterson AJ, Thurman GW, Clay KL, Johnson CA, Ambruso DR,. Analysis of the priming activity of lipids generated during routine storage of platelet concentrates. Transfusion 1996; 36: 133-139.
16. Khan SY, Kelher MR, Heal JM, Blumberg N, Boshkov LK, Phipps R, Gettings KF, McLaughlin NJ, Silliman CC,. Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood 2006; 108: 2455-2462.
17. Middelburg RA, Van Stein D, Zupanska B, Uhrynowska M, Gajic O, Muñiz-Diaz E, Galvez NN, Silliman CC, Krusius T, Wallis JP, Vandenbroucke JP, Briët E, Van Der Bom JG,. Female donors and transfusion-related acute lung injury: a case-referent study from the International TRALI Unisex Research Group. Transfusion 2010; 50: 2447-2454.
18. Ozier Y, Muller JY, Mertes PM, Renaudier P, Aguilon P, Canivet N, Fabrigli P, Rebibo D, Tazerout M, Trophilme C, Willaert B, Caldani C,. Transfusion-related acute lung injury: reports to the French Hemovigilance Network 2007 through 2008. Transfusion 2011; 51: 2102-2110.
19. Vlaar AP, Kulik W, Nieuwland R, Peters CP, Tool AT, van, Bruggen R, Juffermans NP, de, Korte D,. Accumulation of bioactive lipids during storage of blood products is not cell but plasma derived and temperature dependent. Transfusion 2011; 51: 2358-2366.
20. Aoki J, Inoue A, Okudaira S,. Two pathways for lysophosphatidic acid production. Biochim Biophys Acta 2008; 1781: 513-518.
21. Sano T, Baker D, Virag T, Wada A, Yatomi Y, Kobayashi T, Igarashi Y, Tigyi G,. Multiple mechanisms linked to platelet activation result in lysophosphatidic acid and sphingosine 1-phosphate generation in blood. J Biol Chem 2002; 277: 21197-21206.
22. Aoki J, Taira A, Takanezawa Y, Kishi Y, Hama K, Kishimoto T, Mizuno K, Saku K, Taguchi R, Arai H,. Serum lysophosphatidic acid is produced through diverse phospholipase pathways. J Biol Chem 2002; 277: 48737-48744.
23. Pages C, Valet P, Jeanneton O, Zakaroff-Girard A, Barbe P, Record M, Wolf C, Chevy F, Lafontan M, Saulnier-Blache JS,. Alpha2-adrenergic receptor-mediated release of lysophosphatidic acid by adipocytes: a paracrine signal for preadipocyte growth. Lipids 1999; 34 (Suppl): S79.
24. McIntyre TM, Pontsler AV, Silva AR, St Hilaire A, Xu Y, Hinshaw JC, Zimmerman GA, Hama K, Aoki J, Arai H, Prestwich GD,. Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARgamma agonist. Proc Natl Acad Sci U S A 2003; 100: 131-136.
25. van Meeteren LA, Moolenaar WH,. Regulation and biological activities of the autotaxin-LPA axis. Prog Lipid Res 2007; 46: 145-160.
26. Paris A, Nhan T, Cornet E, Perol JP, Malet M, Troussard X,. Performance evaluation of the body fluid mode on the platform Sysmex XE-5000 series automated hematology analyzer. Int J Lab Hematol 2010; 32: 539-547.
27. Kishimoto T, Matsuoka T, Imamura S, Mizuno K,. A novel colorimetric assay for the determination of lysophosphatidic acid in plasma using an enzymatic cycling method. Clin Chim Acta 2003; 333: 59-67.
28. Kishimoto T, Soda Y, Matsuyama Y, Mizuno K,. An enzymatic assay for lysophosphatidylcholine concentration in human serum and plasma. Clin Biochem 2002; 35: 411-416.
29. Ohkawa R, Kishimoto T, Kurano M, Dohi T, Miyauchi K, Daida H, Nagasaki M, Uno K, Hayashi N, Sakai N, Matsuyama N, Nojiri T, Nakamura K, Okubo S, Yokota H, Ikeda H, Yatomi Y,. Development of an enzymatic assay for sphingomyelin with rapid and automatable performances: analysis in healthy subjects and coronary heart disease patients. Clin Biochem 2012; 45: 1463-1470.
30. Takayama M, Itoh S, Nagasaki T, Tanimizu I,. A new enzymatic method for determination of serum choline-containing phospholipids. Clin Chim Acta 1977; 79: 93-98.
31. Nakamura K, Igarashi K, Ide K, Ohkawa R, Okubo S, Yokota H, Masuda A, Oshima N, Takeuchi T, Nangaku M, Okudaira S, Arai H, Ikeda H, Aoki J, Yatomi Y,. Validation of an autotaxin enzyme immunoassay in human serum samples and its application to hypoalbuminemia differentiation. Clin Chim Acta 2008; 388: 51-58.
32. Maslanka K, Smolenska-Sym G, Michur H, Wrõbel A, Lachert E, Brojer E,. Lysophosphatidylcholines: bioactive lipids generated during storage of blood components. Arch Immunol Ther Exp (Warsz) 2012; 60: 55-60.
33. Ruebsaamen K, Liebisch G, Boettcher A, Schmitz G,. Lipidomic analysis of platelet senescence. Transfusion 2010; 50: 1665-1676.
34. Keuren JF, Magdeleyns EJ, Govers-Riemslag JW, Lindhout T, Curvers J,. Effects of storage-induced platelet microparticles on the initiation and propagation phase of blood coagulation. Br J Haematol 2006; 134: 307-313.
35. Horstman LL, Ahn YS,. Platelet microparticles: a wide-angle perspective. Crit Rev Oncol Hematol 1999; 30: 111-142.
36. Bode AP, Knupp CL,. Effect of cold storage on platelet glycoprotein Ib and vesiculation. Transfusion 1994; 34: 690-696.
37. Seghatchian J, Krailadsiri P,. Platelet storage lesion and apoptosis: are they related? Transfus Apher Sci 2001; 24: 103-105.
38. Hornsey VS, Drummond O, McMillan L, Morrison A, Morrison L, MacGregor IR, Prowse CV,. Cold storage of pooled, buffy-coat-derived, leucoreduced platelets in plasma. Vox Sang 2008; 95: 26-32.
39. An S, Bleu T, Hallmark OG, Goetzl EJ,. Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid. J Biol Chem 1998; 273: 7906-7910.
40. Bandoh K, Aoki J, Hosono H, Kobayashi S, Kobayashi T, Murakami-Murofushi K, Tsujimoto M, Arai H, Inoue K,. Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid. J Biol Chem 1999; 274: 27776-27785.
41. Hecht JH, Weiner JA, Post SR, Chun J,. Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex. J Cell Biol 1996; 135: 1071-1083.
42. Kotarsky K, Boketoft A, Bristulf J, Nilsson NE, Norberg A, Hansson S, Owman C, Sillard R, Leeb-Lundberg LM, Olde B,. Lysophosphatidic acid binds to and activates GPR92, a G protein-coupled receptor highly expressed in gastrointestinal lymphocytes. J Pharmacol Exp Ther 2006; 318: 619-628.
43. Noguchi K, Ishii S, Shimizu T,. Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family. J Biol Chem 2003; 278: 25600-25606.
44. Sonoda H, Aoki J, Hiramatsu T, Ishida M, Bandoh K, Nagai Y, Taguchi R, Inoue K, Arai H,. A novel phosphatidic acid-selective phospholipase A1 that produces lysophosphatidic acid. J Biol Chem 2002; 277: 34254-34263.
45. Dusaulcy R, Rancoule C, Gres S, Wanecq E, Colom A, Guigné C, van, Meeteren LA, Moolenaar WH, Valet P, Saulnier-Blache JS,. Adipose-specific disruption of autotaxin enhances nutritional fattening and reduces plasma lysophosphatidic acid. J Lipid Res 2011; 52: 1247-1255.
46. Bolen AL, Naren AP, Yarlagadda S, Beranova-Giorgianni S, Chen L, Norman D, Baker DL, Rowland MM, Best MD, Sano T, Tsukahara T, Liliom K, Igarashi Y, Tigyi G,. The phospholipase A1 activity of lysophospholipase A-I links platelet activation to LPA production during blood coagulation. J Lipid Res 2011; 52: 958-970.
47. Silliman CC, Kelher M, Ambruso DR,. Bioactive lipids from stored cellular blood components: in vitro method is crucial for proper interpretation. Transfusion 2012; 52: 1155-1157; author reply 1157-8.
48. Silliman CC, Moore EE, Kelher MR, Khan SY, Gellar L, Elzi DJ,. Identification of lipids that accumulate during the routine storage of prestorage leukoreduced red blood cells and cause acute lung injury. Transfusion 2011; 51: 2549-2554.
49. Schulze C, Smales C, Rubin LL, Staddon JM,. Lysophosphatidic acid increases tight junction permeability in cultured brain endothelial cells. J Neurochem 1997; 68: 991-1000.
50. Ren Y, Guo L, Tang X, Apparsundaram S, Kitson C, Deguzman J, Fuentes ME, Coyle L, Majmudar R, Allard J, Truitt T, Hamid R, Chen Y, Qian Y, Budd DC,. Comparing the differential effects of LPA on the barrier function of human pulmonary endothelial cells. Microvasc Res 2013; 85: 59-67.
51. Cui MZ,. Lysophosphatidic acid effects on atherosclerosis and thrombosis. Clin Lipidol 2011; 6: 413-426.
52. van Nieuw Amerongen GP, Vermeer MA, van, Hinsbergh VW,. Role of RhoA and Rho kinase in lysophosphatidic acid-induced endothelial barrier dysfunction. Arterioscler Thromb Vasc Biol 2000; 20: E127-133.
53. Itagaki K, Kannan KB, Hauser CJ,. Lysophosphatidic acid triggers calcium entry through a non-store-operated pathway in human neutrophils. J Leukoc Biol 2005; 77: 181-189.
54. Tou JS, Gill JS,. Lysophosphatidic acid increases phosphatidic acid formation, phospholipase D activity and degranulation by human neutrophils. Cell Signal 2005; 17: 77-82.
55. Hashimoto T, Yamashita M, Ohata H, Momose K,. Lysophosphatidic acid enhances in vivo infiltration and activation of guinea pig eosinophils and neutrophils via a Rho/Rho-associated protein kinase-mediated pathway. J Pharmacol Sci 2003; 91: 8-14.
56. Idzko M, Panther E, Corinti S, Morelli A, Ferrari D, Herouy Y, Dichmann S, Mockenhaupt M, Gebicke-Haerter P, Di Virgilio F, Girolomoni G, Norgauer J,. Sphingosine 1-phosphate induces chemotaxis of immature and modulates cytokine-release in mature human dendritic cells for emergence of Th2 immune responses. FASEB J 2002; 16: 625-627.
57. Panther E, Idzko M, Corinti S, Ferrari D, Herouy Y, Mockenhaupt M, Dichmann S, Gebicke-Haerter P, Di Virgilio F, Girolomoni G, Norgauer J,. The influence of lysophosphatidic acid on the functions of human dendritic cells. J Immunol 2002; 169: 4129-4135.
58. Renkl A, Berod L, Mockenhaupt M, Idzko M, Panther E, Termeer C, Elsner P, Huber M, Norgauer J,. Distinct effects of sphingosine-1-phosphate, lysophosphatidic acid and histamine in human and mouse dendritic cells. Int J Mol Med 2004; 13: 203-209.
59. Lin DA, Boyce JA,. Lysophospholipids as mediators of immunity. Adv Immunol 2006; 89: 141-167.